Exhibit 16.1


May 4, 2009

U.S. Securities and Exchange Commission Office of the Chief Accountant 100 F
Street, N.E.
Washington, DC 20549

Commissioners:

We have read Item 4.01 of Form 8-K, dated May 4, 2009, of Trimedyne, Inc. and
agree with the statements concerning our Firm contained therein.

Very truly yours,

/S/ MCKENNON WILSON & MORGAN LLP
McKennon Wilson & Morgan LLP